selenic acid has been researched along with Ophthalmoplegia, Progressive Supranuclear in 1 studies
Selenic Acid: A strong dibasic acid with the molecular formula H2SeO4. Included under this heading is the acid form, and inorganic salts of dihydrogen selenium tetraoxide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vivash, L | 1 |
| Bertram, KL | 1 |
| Malpas, CB | 1 |
| Marotta, C | 1 |
| Harding, IH | 1 |
| Kolbe, S | 1 |
| Fielding, J | 1 |
| Clough, M | 1 |
| Lewis, SJG | 1 |
| Tisch, S | 1 |
| Evans, AH | 1 |
| O'Sullivan, JD | 1 |
| Kimber, T | 1 |
| Darby, D | 1 |
| Churilov, L | 1 |
| Law, M | 1 |
| Hovens, CM | 1 |
| Velakoulis, D | 1 |
| O'Brien, TJ | 1 |
1 trial available for selenic acid and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial.
Topics: Australia; Clinical Trials, Phase II as Topic; Double-Blind Method; Humans; Randomized Controlled Tr | 2021 |